Location: Home
  • search
  • go
  • Relate News
  • 2/2/2020Korean Pharma and Biotech Cos Expedite Entry into China
  • 1/23/2020Recent Executive Moves
  • 1/23/2020Financial-related Company News in Brief
  • 1/23/2020Gilead Assesses Ebola Drug as Possible Coronavirus Treatment
  • 1/23/2020Onconova Therapeutics Regains Rigosertib Rights in Greater China
  • 1/23/2020Amgen Pledges to Expand Asian Presence
  • 1/22/2020Celebrity Doctor Pay Exposes China's Healthcare Gap
  • 1/22/2020Impact of the China-U.S. Trade Deal on Intellectual Property Protectio...
  • 1/22/2020BeiGene Aims to Take on Merck's Star Aniticancer Drug Keytruda with Ti...
  • 1/21/2020NMPA Announces Implementation of Four Series Q ICH Guidelines in China
  • 1/20/2020Chi-Med Reports Positive Surufatinib Phase III SANET-p Study
  • 1/20/2020Zydus and CMS enter into a License Agreement for Desidustat in Greater...
  • 1/20/2020National Primary Healthcare Working Conference Highlights Key Tasks in...
  • 1/20/2020NMPA Publicizes List of Reference Formulations for Generic Drug Equiva...
  • 1/17/2020I-Mab Biopharma Nabs $104M from Nasdaq IPO
  • 1/17/2020Chinese Pharmaceutical Industry Growth Continued to Slow in 2019
  • 1/16/2020Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar
  • 1/16/2020Wuxi Biologics Strikes Deal to Take Over A Bayer Plant in Germany
  • 1/15/2020Review of Chinese Drug Registration Applications and Approvals in 2019
  • 1/15/2020MNC New Product Launches in China Down Slightly to 37 During 2019
  • 1/15/2020National Healthcare Security Working Conference Lays Out Major Tasks i...
  • 1/15/2020U.S. and China Inks Phase One Trade Deal
  • 1/14/2020China Adds Over 6,000 TCM Clinics in 2019
  • 1/14/2020Ambrx and Sino Biopharma Announce Collaboration to Develop Two Next-Ge...
  • 1/14/2020HitGen Enters into DEL-Based Drug Discovery Partnership with Kymera
  • 1/14/2020Chi-Med Initiates a PII Trial of Surufatinib in Combo with Toripalimab...
  • 1/13/2020BeiGene In-licences Candidates from EUSA Pharma
  • 1/11/2020Recent Executive Moves
  • 1/11/2020NMPA Clears Phase 3 Trial for SB12, Samsung Bioepis' Biosimilar Eculiz...
  • 1/8/2020CDE Seeks Comments on Guidelines for Generic Drug Research of Paclitax...
  • Page:127/360 Total number of articles:10791: [First][<<] [125] [126] [127] [128] [129] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group